BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6806416)

  • 21. [Growth hormone, prolactin, LH and FSH secretion in tissue culture of pituitary adenomas (author's transl)].
    Kubo O; Himuro H; Kamijo Y; Kitamura K; Demura R
    No Shinkei Geka; 1977 Oct; 5(11):1135-41. PubMed ID: 917213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of 6 pituitary hormones in the cerebrospinal fluid. Control subjects, prolactin adenomas, empty sella syndrome and hypothalamic disorders (author's transl)].
    Turpin G; Heshmati HM; Roger M; Cesselin E; Lagoguey M; Baulieu JL; de Gennes JL
    Ann Endocrinol (Paris); 1979; 40(4):425-6. PubMed ID: 518022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of gonadotroph adenomas in women.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
    Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
    Shimatsu A; Murabe H; Nakamura Y; Mizuta H; Ihara C; Nakao K
    Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prolactin adenomas in children (author's transl)].
    Lucas C; Guibout M; Jaquet P; Grisoli F; Giraud F
    Arch Fr Pediatr; 1980 Feb; 37(2):79-86. PubMed ID: 7396649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin-secreting pituitary microadenoma: detection and evaluation.
    Wiebe RH; Hammond CB; Handwerger S
    Fertil Steril; 1978 Mar; 29(3):282-6. PubMed ID: 640047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
    Berezin M; Olchovsky D; Pines A; Tadmor R; Lunenfeld B
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1220-3. PubMed ID: 6436289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma.
    Marrs RP; Bertolli SJ; Kletzky OA
    Am J Obstet Gynecol; 1980 Nov; 138(6):620-5. PubMed ID: 6776812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
    Barbarino A; De Marinis L; Maira G; Menini E; Anile C
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1352-5. PubMed ID: 8077332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.
    Klijn JG; Lamberts SW; de Jong FH; Birkenhäger JC
    Fertil Steril; 1981 Feb; 35(2):155-61. PubMed ID: 6781936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent advances in hormonal detection of pituitary somatotropic adenomas (author's transl)].
    Turpin G; Heshmati HM; De Gennes JL
    Ann Med Interne (Paris); 1982; 133(1):17-22. PubMed ID: 6802054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
    Blanco C; Lucas T; Alcañiz J; Davila N; Serrano P; Barcelò B; Estrada J
    J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.